{"success":true,"data":{"pressRelease":{"id":"48757","rtpr_id":"nPn36M0BNa","ticker":"KOD","exchange":"NASDAQ","all_tickers":["KOD"],"title":"Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference","author":"PR Newswire","published_at":"2026-05-28T22:10:13.397Z","article_body":"Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference\n\nPR Newswire\n\nPALO ALTO, Calif., May 28, 2026\n\nPALO ALTO, Calif., May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq:\nKOD), a precommercial retina-focused biotechnology company committed to\nresearching, developing and commercializing transformative therapeutics, today\nannounced that Victor Perlroth, M.D., Chief Executive Officer, will present at\nthe 2026 Jefferies Global Healthcare Conference in New York on Thursday, June\n4, 2026, at 11:40am ET (8:40am PT).\n\nA live webcast of the presentation will be available on the \"Events and\nPresentations\" section of Kodiak's website at http://ir.kodiak.com/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4699269-1&h=42348397&u=http%3A%2F%2Fir.kodiak.com%2F&a=http%3A%2F%2Fir.kodiak.com%2F)\nand will remain available for replay for a limited time following the event.\n\nAbout Kodiak Sciences Inc.\n\nKodiak Sciences (Nasdaq: KOD) is a precommercial retina-focused biotechnology\ncompany committed to researching, developing and commercializing\ntransformative therapeutics. We are focused on bringing new science to the\ndesign and manufacture of next-generation retinal medicines to prevent and\ntreat the leading causes of blindness globally. We are developing a portfolio\nof three late-stage clinical programs: Zenkuda™ (tarcocimab tedromer),\nKSI-501 and KSI-101.\n\nFor more information, please visit www.kodiak.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4699269-1&h=1968258845&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4418773-1%26h%3D1987127448%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4380048-1%2526h%253D1701614659%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4354712-1%252526h%25253D3009044844%252526u%25253Dhttp%2525253A%2525252F%2525252Fwww.kodiak.com%2525252F%252526a%25253Dwww.kodiak.com%2526a%253Dwww.kodiak.com%26a%3Dwww.kodiak.com&a=www.kodiak.com)\n.\n\nKodiak(®), Kodiak Sciences(®), ABC(®), ABC Platform(®), ABCD™ and the\nKodiak logo are registered trademarks or trademarks of Kodiak Sciences\nInc. in various global jurisdictions.\n\nView original\ncontent:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2026-jefferies-global-healthcare-conference-302785078.html\n(https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2026-jefferies-global-healthcare-conference-302785078.html)\n\nSOURCE Kodiak Sciences Inc.\n\n\n\nKodiak Contact: John Borgeson, Chief Financial Officer, Tel (650) 281-0850, ir@kodiak.com\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn36M0BNa","title":"Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference","author":"PR Newswire","ticker":"KOD","created":"2026-05-28T22:10:13.397Z","tickers":["KOD"],"exchange":"NASDAQ","article_body":"Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference\n\nPR Newswire\n\nPALO ALTO, Calif., May 28, 2026\n\nPALO ALTO, Calif., May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq:\nKOD), a precommercial retina-focused biotechnology company committed to\nresearching, developing and commercializing transformative therapeutics, today\nannounced that Victor Perlroth, M.D., Chief Executive Officer, will present at\nthe 2026 Jefferies Global Healthcare Conference in New York on Thursday, June\n4, 2026, at 11:40am ET (8:40am PT).\n\nA live webcast of the presentation will be available on the \"Events and\nPresentations\" section of Kodiak's website at http://ir.kodiak.com/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4699269-1&h=42348397&u=http%3A%2F%2Fir.kodiak.com%2F&a=http%3A%2F%2Fir.kodiak.com%2F)\nand will remain available for replay for a limited time following the event.\n\nAbout Kodiak Sciences Inc.\n\nKodiak Sciences (Nasdaq: KOD) is a precommercial retina-focused biotechnology\ncompany committed to researching, developing and commercializing\ntransformative therapeutics. We are focused on bringing new science to the\ndesign and manufacture of next-generation retinal medicines to prevent and\ntreat the leading causes of blindness globally. We are developing a portfolio\nof three late-stage clinical programs: Zenkuda™ (tarcocimab tedromer),\nKSI-501 and KSI-101.\n\nFor more information, please visit www.kodiak.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4699269-1&h=1968258845&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4418773-1%26h%3D1987127448%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4380048-1%2526h%253D1701614659%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4354712-1%252526h%25253D3009044844%252526u%25253Dhttp%2525253A%2525252F%2525252Fwww.kodiak.com%2525252F%252526a%25253Dwww.kodiak.com%2526a%253Dwww.kodiak.com%26a%3Dwww.kodiak.com&a=www.kodiak.com)\n.\n\nKodiak(®), Kodiak Sciences(®), ABC(®), ABC Platform(®), ABCD™ and the\nKodiak logo are registered trademarks or trademarks of Kodiak Sciences\nInc. in various global jurisdictions.\n\nView original\ncontent:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2026-jefferies-global-healthcare-conference-302785078.html\n(https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2026-jefferies-global-healthcare-conference-302785078.html)\n\nSOURCE Kodiak Sciences Inc.\n\n\n\nKodiak Contact: John Borgeson, Chief Financial Officer, Tel (650) 281-0850, ir@kodiak.com\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-28T22:10:13.438741176Z","server_sent_at_ms":1780006213438},"received_at":"2026-05-28T22:10:13.506Z","source_url":"https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2026-jefferies-global-healthcare-conference-302785078.html"},"analysis":{"id":"38190","press_release_id":"48757","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Kodiak Sciences CEO Victor Perlroth will present at the 2026 Jefferies Global Healthcare Conference on June 4, 2026.\n\nThe presentation is scheduled for 11:40am ET in New York and will be webcast live on Kodiak's investor relations website.\n\nThe release serves as a standard calendar notice with no new operational or financial disclosures.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference appearance -- monitor for any ad-hoc updates during the session."},"keyFigures":{},"quotedText":"Victor Perlroth, M.D., Chief Executive Officer, will present at the 2026 Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026, at 11:40am ET","namedEntities":{"people":[{"name":"Victor Perlroth","role":"CEO"},{"name":"John Borgeson","role":"CFO"}],"products":["Zenkuda","tarcocimab tedromer","KSI-501","KSI-101"],"companies":[{"name":"Kodiak Sciences Inc.","ticker":"KOD"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine conference presentation announcement. No new clinical data, financial results, or strategic developments disclosed. Standard investor relations activity."},"tickerRelevance":{"others":[],"primary":"KOD"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine_ir","sectorWeight":"biotech","householdBrandBoost":0}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Kodiak Sciences CEO Victor Perlroth will present at the 2026 Jefferies Global Healthcare Conference on June 4, 2026.\n\nThe presentation is scheduled for 11:40am ET in New York and will be webcast live on Kodiak's investor relations website.\n\nThe release serves as a standard calendar notice with no new operational or financial disclosures.","key_figures":{},"named_entities":{"people":[{"name":"Victor Perlroth","role":"CEO"},{"name":"John Borgeson","role":"CFO"}],"products":["Zenkuda","tarcocimab tedromer","KSI-501","KSI-101"],"companies":[{"name":"Kodiak Sciences Inc.","ticker":"KOD"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-28T22:10:29.894Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine_ir","sectorWeight":"biotech","householdBrandBoost":0}},"durationMs":16377,"modelName":"george-droid-qwen-72b"}}